PCE Online Continuing Education for Nurse Practitioners and Physician Assistants With Complimentary CE/CME Credits
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 12/15/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCase
- Expiration Date: 12/20/21
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Conference Coverage
- Expiration Date: 1/03/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 1/11/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 2/25/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 3/19/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 3/19/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 3/19/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 3/19/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 3/19/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- eCourse
- Expiration Date: 4/25/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Clinical Thought
- Expiration Date: 5/20/22
- Not certified for credit.
- Clinical Thought
- Expiration Date: 5/20/22
- Not certified for credit.
- Expert Insights
- Expiration Date: 6/15/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- BriefCase
- Expiration Date: 7/14/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 7/29/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Virtual Lecture
- Expiration Date: 7/29/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- PCE On Demand Live Presentation
- Expiration Date: 8/16/22
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
- Clinical Thought
- Expiration Date: 8/23/22
- Not certified for credit.
- Clinical Thought
- Expiration Date: 8/23/22
- Not certified for credit.
Relapsed/Refractory Multiple Myeloma: Integrating Novel Agents into the Treatment Paradigm
View Activity
The Evolving Landscape of Prostate Cancer Management
View Activity
Managing Patients Treated With CAR T-Cell Therapy
View Activity
Therapeutic Advances in Metastatic HER2-Positive Breast Cancer
View Activity
Immune Checkpoint Inhibitor Therapy: Recognition and Management of Adverse Events
View Activity
Novel Therapies in Advanced Urothelial Cancer: Effective Management of Treatment-Related Toxicities
View Activity
Small Cell Lung Cancer: A Changing Treatment Paradigm
View Activity
Precision Oncology: Identifying and Treating Patients With Non-small Cell Lung Cancer
View Activity
Update on Novel Therapies in Acute Lymphoblastic Leukemia
View Activity
ASH 2020: Highlights in Research and Patient Care
View Activity
Individualizing Therapy for Chronic Lymphocytic Leukemia: New Options
View Activity
PARP Inhibition in Ovarian Cancer: Current Evidence
View Activity
Integrating New Therapies Into the Treatment of Advanced Prostate Cancer
View Activity
New Options for Advanced Renal Cell Carcinoma: Targeted and Immunotherapies
View Activity
Updates in Advanced Pancreatic Cancer: Integrating New Therapies Into Clinical Practice
View Activity
Applying Recent Advances in Metastatic Colorectal Cancer to Improving Patient Care
View Activity
The Evolving Treatment Landscape for Advanced Gastric Cancer: New Data on Novel Treatment Options
View Activity
New and Emerging Options for Hematologic Disease–Related Anemia
View Activity
Keeping Maintenance a Holiday in Advanced Ovarian Cancer: Part 1
View Activity
Keeping Maintenance a Holiday in Advanced Ovarian Cancer: Part 2
View Activity
The Emerging Role of Minimal Residual Disease Testing in Hematologic Malignancies
View Activity
Addressing Barriers to Improved Outcomes in African American Patients With Multiple Myeloma
View Activity
Immune Checkpoint Inhibitors in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
View Activity
Opening the Door to Systemic Therapies for Advanced Basal Cell Carcinoma
View Activity
Targeted Therapies in B-Cell Malignancies: Management of Adverse Events in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma
View Activity
Expanding the Treatment Landscape for Urothelial Cancer
View Activity
Targeting the Clinical Challenges of Metastatic HER2-Positive Breast Cancer With Novel Agents
View Activity
Tackling the Complexities of Relapsed/Refractory Follicular Lymphoma: An Update on Recent Advances
View Activity
Maximizing the Potential of Novel Therapies for Prostate Cancer
View Activity
The Expanding Treatment Landscape for Triple-Negative Breast Cancer
View Activity
Changing the Treatment of Endometrial Cancer: Novel and Emerging Strategies
View Activity
Navigating the Expanding Options for Relapsed/Refractory Multiple Myeloma
View Activity
Optimizing Use of Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
View Activity
Biomarkers, Molecular Analysis, and Choice of Therapy in NSCLC
View Activity
PARP Inhibitor Therapy for Ovarian Cancer: Recent Advances and Existing Challenges
View Activity
Addressing Racial Disparities in Multiple Myeloma Treatment
View Activity
Improving Enrollment of African American Patients in Clinical Trials for Multiple Myeloma
View Activity